Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitagliptin in Patients With Type 2 Diabetes and Chronic Renal Insufficiency
NCT00095056Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Oct 2004
- Primary completion
- Jul 2006
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of sitagliptin in type 2 diabetes mellitus (T2DM), sponsored by Merck & Co.. Started Oct 2004; status: completed.
02
Drugs
sitagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00095056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00095056.